Former OpenAI Chief Product Officer Kevin Weil founded Warp Sciences, raising a $215 million Series A at an $865 million valuation
Warp Sciences, an AI scientific research startup founded by former OpenAI Chief Product Officer Kevin Weil, has emerged from stealth, completing a $215 million Series A funding round at a post-money valuation of $865 million, led by Lightspeed Venture Partners. The company, founded in San Francisco with a team of about 20 people, plans to use AI, robotics, and automated laboratories to help pharmaceutical companies screen molecular variants in drug development, without developing drugs itself. The approach is still at an early stage, and whether it can run stably and improve experimental efficiency remains to be verified.
Warp Sciences, an AI scientific research startup founded by former OpenAI Chief Product Officer Kevin Weil, has emerged from stealth, completing a $215 million Series A funding round at a post-money valuation of $865 million, led by Lightspeed Venture Partners. The company, founded in San Francisco with a team of about 20 people, plans to use AI, robotics, and automated laboratories to help pharmaceutical companies screen molecular variants in drug development, without developing drugs itself. T
Matched fieldsTitle、Summary、Body